Skip to main content

Clinical Trials Using Temozolomide

Review the clinical trials studying temozolomide on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 76-89 of 89

Medication Combinations of Dasatinib, Quercetin, Fisetin and Temozolomide for the Treatment of Previously Treated Glioma with Residual Disease
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Status: Active
Location: Nationwide Children's Hospital, Columbus, Ohio
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
Status: Active
Location: See ClinicalTrials.gov
Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies
Status: Enrolling by Invitation
Location: See ClinicalTrials.gov
PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients with Glioblastoma
Status: Approved
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients with Progressing Metastatic Neuroendocrine Carcinomas
Status: Approved
Location: Roswell Park Cancer Institute, Buffalo, New York
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors that have Returned after Previous Treatment
Status: Temporarily Closed to Accrual
Location: 34 locations
Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma
Status: Temporarily Closed to Accrual
Location: See ClinicalTrials.gov
Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
Status: Temporarily Closed to Accrual
Location: 395 locations
Hyperpolarized Imaging in Diagnosing Patients with Glioma
Status: Active
Location: 2 locations
Hyperpolarized Carbon C 13 Pyruvate MRI for the Diagnosis of Patients with Primary Central Nervous System Lymphoma
Status: Active
Location: University of California San Francisco, San Francisco, California
Rapid Infusion of Dinutuximab with Chemotherapy for the Treatment of Relapsed, Refractory or Persistent High Risk Neuroblastoma or Ganglioneuroblastoma
Status: Active
Location: Children's Hospital Los Angeles, Los Angeles, California
Implantable Microdevice for the Delivery of Drugs and their Effect on Tumors in Patients with Sarcoma
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Evaluating Advanced MRI Methods for Adapting Radiation Therapy for Patients with Newly Diagnosed High Grade Glioma
Status: Active
Location: NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York